Health Trials

Relapsed Chronic Lymphocytic Leukemia

2

Review clinical trials related to Relapsed Chronic Lymphocytic Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

This is a Phase II study following subjects proceeding with our Institutional non-myeloablative cyclophosphamide/ fludarabine/total body irradiation (TBI) preparative regimen followed by a related, unrelated, or partially matched family donor stem cell infusion using post-transplant cyclophosphamide (PTCy), sirolimus and MMF GVHD prophylaxis.

Participants needed: 56
Trial details
Phase: Phase 2Age: Up to 75Biological sex: AllType: InterventionalSponsor: Masonic Cancer Center, University of MinnesotaUpdated: Jul 1, 2025Locations: 1
Eligibility criteria

Age 0 to 75 years of age with Karnofsky score ≥ 70% (≥ 16 years) or Lansky score... [+12]

Pregnant or breast feeding. The agents used in this study include Pregnancy Cate... [+6]

Read more
Status: Recruiting

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

The purpose of this study is to collect medical informations and samples from refractory and/or relapsed chronic lymphocytic leukemia during or after venetoclax treatment, in order to evaluate the frequency of resistance mechanisms.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, Clermont-FerrandUpdated: Jan 9, 2024Locations: 14
Eligibility criteria

Age greater than or equal to 18 years old; [+6]

Read more